Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for MandA

Boehringer rivals Zoetis' top spot as H1 highlights duel between innovation and acquisition

Half-way through fiscal 2017, most of the leading animal health companies are enjoying strong growth. The last six months has encapsulated how the industry leaders are boosting their top lines organically and via various sizes of acquisitions. Animal Pharm editor Joseph Harvey maps out a shifting top 10 ranking in animal health.
Financial Results M&A

MSD buys Austrian production complex

US animal health company MSD Animal Health is to increase its global vaccine output with the purchase of an Austrian production facility.

Europe Austria

A carousel of companies: Inside the industry consolidation of 1990-2000

With the animal health sector currently experiencing a temporary lull in major M&A deals, the recent company rankings have remained fairly stable. However, to understand today's industry landscape, a history of consolidation has to be reviewed. Editor Joseph Harvey dug up Animal Pharm's time capsule to inspect over 25 years of comings and goings. 

M&A Markets

Zoetis completes Nexvet acquisition, begins R&D integration

Zoetis has completed its acquisition of Irish pet therapeutics firm Nexvet Biopharma. 

M&A Zoetis

George Gunn says animal health industry is now ready to stand on its own four feet

Speaking at Kilfovet's 20th anniversary seminar in Munich, Dr George Gunn outlined how the animal health industry has been molded over the last 20 years and what firms can expect for the future. Animal Pharm analyst Sian Lazell was in attendance to hear about the role of M&A, product innovation and areas of potential opportunity.

M&A Markets

Animal Pharm M&A table 2017

Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2017.

M&A Commercial

UK feed company makes foray into Turkish market

UK animal feed company Devenish is broadening its market reach with a major investment in Turkey.

Feed & Additives M&A

Ecuphar, Animalcare merger deal finalized

The merger between Belgian firm Ecuphar and UK business Animalcare has closed.

Generics M&A

Nextmune opens pathway to US allergy market via Spectrum acquisition

Swedish company Nextmune has created Spectrum Veterinary, a firm dedicated to developing allergy treatments for companion animals.

Companion Animals Dermatology

Brazil's grande oportunidade requires 'technification' and enhanced regulations

Brazil's sheer size makes it a clear contender to become a leading light in the animal health sector amongst developing nations. With this in mind, Animal Pharm editor Joseph Harvey travelled to São Paulo to learn about Brazil's growth drivers and hindrances, as well as to hear a very honest insight into the country's regulatory situation.

Policy & Regulation Brazil

Animal Pharm Podcast #3: Klifovet highlights 20 years of industry change

Opening Kilfovet's 20th anniversary seminar in Munich, managing director of the firm Dr Klaus Hellmann spoke of an interesting time in animal health. Animal Pharm analyst Sian Lazell attended the event to hear how the industry has changed in the last few decades.

Policy & Regulation Deals

Animal Pharm Podcast #2: Brazil's turmoil creates platform for growth

Last week, Animal Pharm editor Joseph Harvey attended the Animal Health Latin America conference in São Paulo. The podcast below provides an overview of the key topics impacting the Brazilian animal health market.

Brazil Legal